Eurobio Scientific Team

Downloads

Marketing Tools

EurobioPlex

Our production and Research and Development sites are located in France close to Paris.

Our main commitment lies in the desire to provide our customers with innovative and quality solutions combined with high-level services.

Flyer

EBX-Listing

Eurobio Scientific develops and produces One-step Real-time qPCR kits for human infectious diseases

EBX-001

EurobioPlex Bordetella pertussis and Bordetella parapertussis

EBX-005

EurobioPlex Leptospire

EBX-009

EurobioPlex Chikungunya / Dengue

EBX-010

EurobioPlex HEV

EBX-011

EurobioPlex alpha Herpesvirus

EBX-012

EurobioPlex Zika Virus

EBX-013

EurobioPlex Bartonella

EBX-020

EurobioPlex Community-acquired bacterial meningitis

EBX-022

EurobioPlex Noenatal bacterial meningitis

EBX-041

EurobioPlex SARS-CoV-2 Multiplex

EBX-042

EurobioPlex FluCoSyn

EBX-047

EurobioPlex SARS-CoV-2 Fast-SVD Screening and Variants Detection

EBX-048

EurobioPlex SARS-CoV-2 Fast-SVT Screening and VOC typing

EBX-050

EurobioPlex Chikungunya/Dengue/Leptospire

EBX-051

EurobioPlex Multi-Fast STI

EBX-073

EurobioPlex DermaScreen

EBX-100

EurobioPlex Sperm MessengerTM 4 fertility

EndoPredict® & Prolaris®

Confidence in cancer therapy decisions

EndoPredict® Breast Cancer Prognostic Test is a genomic test that helps guide important treatment decisions for your cancer journey.

Flyer

Patientes Brochure

Gain Certainty in Breast Cancer Treatment

15 years and the benefit from chemotherapy

Gain Certainty in Breast Cancer Treatment

TECO® FungiLine

TECO® FungiLine

The TECO® FungiLine Fast consists of a fluorescence analyzer (FIC-Q100N) and fluorescence-based rapid tests (TECO® Fast Lateral Flow Assays) for the detection of the most common invasive fungal infections. The combination of analyzer and Fast LFAs can be established in every laboratory.

Flyer

TECO® FungiLine Fast

Routine diagnostics for the detection of fungal diseases

Biosafety: PKA products

Chromogenic assay for the determination of Prekallikrein Activator (PKA) in Human Blood Products and Biologicals according to the European Pharmacopoeia.

The assay can be performed as rate method or endpoint. The PKA standard and kit control are calibrated against the 3rd international standard for PKA.

Flyer

PKA Range

QC of human IgG and albumin products in compliance with the European Pharmacopoeia

en_GB
Scroll to Top